Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0001193125-26-236841

Options or other derivatives

  • Director acquired 67,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Klencke Barbara · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-20 Grant or award : show line 1 in the form Stock Option (Right to Buy) +67,000 67,000 D
Loading xslF345X06/ownership.xml…